COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD
HC Q study #70
Source   PDF   Share   Tweet
See all 143 studies
6/30
Positive
Late treatment study
Mikami et al., J. Gen. Intern. Med., doi:10.1007/s11606-020-05983-z (Peer Reviewed)
Risk Factors for Mortality in Patients with COVID-19 in New York City
HC Q decreases mortality, HR 0.53 (CI 0.41–0.67). IPTW adjustment does not significantly change HR 0.53 (0.41-0.68). Retrospective 6,000 patients in New York City.
death, ↓47.0%, p<0.0001
Source   PDF   Share   Tweet
See all 143 studies
Please send us corrections, updates, or comments.
Submit